Cardiovascular Stroke Prevention and Management Using the Principles of Cellular Medicine

Abstract

Cerebrovascular disease generally refers to the abnormality of the brain, and it is usually caused by the pathologic process of blood vessels. After heart disease and cancer, stroke is the third most common cause of death in the developed world. Stroke can be classified based on the evolution and duration of the symptoms experienced by the patient. From the perspectives of human, family, and the society, stroke is a costly disease. In 2015, the total cost of stroke in the EU was estimated at about €45 Billion. Also, in the same year, the total direct and indirect cost of stroke in the United States of America was calculated as $103.50 billion annually. Meanwhile, stroke can be conveniently classified as two processes, based on pathologic anatomy and pathophysiology. The first process is; hpoxia, ischaemia, and infarction. This is usually caused by the pathology of blood supply and the impairment of oxygenation to the central nervous system (CNS) tissue. The second process is haemorrhage, and this is usually due to the rupture of blood vessels to the CNS. Most of the thrombotic arterial occlusions are caused by atherosclerosis, while primary brain parenchymal haemorrhage is most commonly due to hypertension. Cellular medicine is an approach to healthcare which focuses on the aetiology of diseases and develops treatment for the diseases by studying; biological processes, structures and functions of biomolecules, and cell physiology, in order to understand abnormal biological function at the cellular level. Research in the field of cellular medicine have revealed that atherosclerosis, the main cause of cardiovascular and cerebrovascular diseases, can be reversed using cellular medicine. The research also showed that atherosclerosis is an early form of full blown scurvy, thus both scurvy and atherosclerosis have the same cause, which is vitamin C deficiency.